vs
Side-by-side financial comparison of Vita Coco Company, Inc. (COCO) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.
Vita Coco Company, Inc. is the larger business by last-quarter revenue ($179.8M vs $150.6M, roughly 1.2× GLAUKOS Corp). Vita Coco Company, Inc. runs the higher net margin — 17.0% vs 6.2%, a 10.7% gap on every dollar of revenue. On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs 37.3%). Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs 11.7%).
The Vita Coco Company, doing business simply as Vita Coco, is an American beverage company which mainly sells coconut water. The largest brand globally in coconut/plant waters, Vita Coco has operations in 31 countries as of 2016. It is a benefit corporation. The company is owned by All Market Inc.
Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.
COCO vs GKOS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $179.8M | $150.6M |
| Net Profit | $30.5M | $9.4M |
| Gross Margin | 39.9% | 77.9% |
| Operating Margin | 18.7% | 9.0% |
| Net Margin | 17.0% | 6.2% |
| Revenue YoY | 37.3% | 41.2% |
| Net Profit YoY | 61.4% | — |
| EPS (diluted) | $0.50 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $179.8M | $150.6M | ||
| Q4 25 | $127.8M | $143.1M | ||
| Q3 25 | $182.3M | $133.5M | ||
| Q2 25 | $168.8M | $124.1M | ||
| Q1 25 | $130.9M | $106.7M | ||
| Q4 24 | $127.3M | $105.5M | ||
| Q3 24 | $132.9M | $96.7M | ||
| Q2 24 | $144.1M | $95.7M |
| Q1 26 | $30.5M | $9.4M | ||
| Q4 25 | $5.5M | $-133.7M | ||
| Q3 25 | $24.0M | $-16.2M | ||
| Q2 25 | $22.9M | $-19.7M | ||
| Q1 25 | $18.9M | $-18.1M | ||
| Q4 24 | $3.4M | $-33.6M | ||
| Q3 24 | $19.3M | $-21.4M | ||
| Q2 24 | $19.1M | $-50.5M |
| Q1 26 | 39.9% | 77.9% | ||
| Q4 25 | 34.9% | -1.1% | ||
| Q3 25 | 37.7% | 78.4% | ||
| Q2 25 | 36.3% | 78.3% | ||
| Q1 25 | 36.7% | 77.2% | ||
| Q4 24 | 32.5% | 72.9% | ||
| Q3 24 | 38.8% | 76.6% | ||
| Q2 24 | 40.8% | 76.4% |
| Q1 26 | 18.7% | 9.0% | ||
| Q4 25 | 8.0% | -97.7% | ||
| Q3 25 | 15.3% | -12.3% | ||
| Q2 25 | 14.9% | -18.3% | ||
| Q1 25 | 14.7% | -19.4% | ||
| Q4 24 | 3.4% | -27.2% | ||
| Q3 24 | 15.5% | -25.5% | ||
| Q2 24 | 20.8% | -31.3% |
| Q1 26 | 17.0% | 6.2% | ||
| Q4 25 | 4.3% | -93.4% | ||
| Q3 25 | 13.2% | -12.2% | ||
| Q2 25 | 13.6% | -15.8% | ||
| Q1 25 | 14.4% | -17.0% | ||
| Q4 24 | 2.6% | -31.8% | ||
| Q3 24 | 14.5% | -22.1% | ||
| Q2 24 | 13.2% | -52.8% |
| Q1 26 | $0.50 | — | ||
| Q4 25 | $0.10 | $-2.34 | ||
| Q3 25 | $0.40 | $-0.28 | ||
| Q2 25 | $0.38 | $-0.34 | ||
| Q1 25 | $0.31 | $-0.32 | ||
| Q4 24 | $0.06 | $-0.56 | ||
| Q3 24 | $0.32 | $-0.39 | ||
| Q2 24 | $0.32 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $201.9M | $276.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $352.2M | $670.9M |
| Total Assets | $488.3M | $893.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $201.9M | $276.7M | ||
| Q4 25 | $196.9M | $90.8M | ||
| Q3 25 | $203.7M | $98.2M | ||
| Q2 25 | $167.0M | $100.8M | ||
| Q1 25 | $153.6M | $114.3M | ||
| Q4 24 | $164.7M | $169.6M | ||
| Q3 24 | $156.7M | $100.1M | ||
| Q2 24 | $150.1M | $68.1M |
| Q1 26 | $352.2M | $670.9M | ||
| Q4 25 | $331.5M | $656.2M | ||
| Q3 25 | $323.7M | $769.5M | ||
| Q2 25 | $296.9M | $765.1M | ||
| Q1 25 | $277.9M | $764.0M | ||
| Q4 24 | $258.8M | $766.9M | ||
| Q3 24 | $252.1M | $668.5M | ||
| Q2 24 | $232.0M | $665.2M |
| Q1 26 | $488.3M | $893.3M | ||
| Q4 25 | $461.2M | $893.5M | ||
| Q3 25 | $461.3M | $999.4M | ||
| Q2 25 | $421.1M | $987.0M | ||
| Q1 25 | $384.0M | $966.2M | ||
| Q4 24 | $362.4M | $974.8M | ||
| Q3 24 | $353.1M | $926.5M | ||
| Q2 24 | $323.0M | $919.7M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COCO
| Subtotal | $148.2M | 82% |
| Private Label | $24.4M | 14% |
| Other | $7.2M | 4% |
GKOS
Segment breakdown not available.
